Reading time: 4 minutes Keighley Reisenauer One of the “hot button” topics right now in the cancer therapeutics industry is precision medicine. This is a practice whereby a tumor’s genetics, immune landscape, and biomarkers are compiled and evaluated holistically in order to more accurately make treatment decisions. Breast cancer especially has benefited from the targeted... Continue Reading →
Freaky Friday: What happens when cancer cells swap mitochondria?
Keighley Reisenauer Reading time: 3 minutes Think back to 2003, when Jamie Lee Curtis and Lindsay Lohan swapped bodies as mother and daughter in the flick Freaky Friday. While their bodies looked the same, their behaviors changed as each brought their own personality to the other’s lives. Movies love this idea of swapping bodies, brains,... Continue Reading →
Preventing cell death decreases breast cancer recurrence
Reading time: 5 minutes Keighley Reisenauer Breast cancer is a collection of diseases, organized into subtypes designating which treatments may be best for the patient and how aggressive the cancer is likely to be. One thing that is universal across all subtypes, though, is what makes them worse: metastasis. When cancer metastasizes, it spreads across... Continue Reading →
The Other EMT: Exploring the controversial driver of metastasis
Reading time: 5 minutes Keighley Reisenauer Google “EMT,” and you’re likely to see images of paramedics and ambulances. However, there is another EMT that plays a much different role in disease and illness. Epithelial to mesenchymal transition (EMT) is normally associated with processes such as wound healing and development. Cancer hijacks EMT to participate in... Continue Reading →